CIK 0001849296
- Non-accelerated filer
- Emerging growth company
OKYO Pharma Ltd
Sign in to watch- Ticker
- OKYO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Entity type
- Other
- Phone
- +44 2074952379
- Business address
- 55 PARK LANE, LONDON, United Kingdom, W1K 1NA
- 4 Grant or award Director acquired 300,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Executive Chairman acquired 569,539 shares (other)
- 4 Open-market buy Director bought 16,670 shares at $1.50 ($25,005)
- 4 Open-market buy Executive Chairman bought 5,800,000 shares at $0.08 ($440,800)
- 4 Open-market buy Chief Executive Officer bought 12,500 shares at $4.00 ($50,000)
- 4 Open-market buy Non-Executive Chairman bought 37,500 shares at $4.00 ($150,000)
- 4/A Open-market buy Non-Executive Chairman bought 25,000 shares at $3.87 ($96,750)
- 4 Open-market buy Non-Executive Chairman bought 1,625,000 shares at $0.06 ($96,688)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 3 · 41 filings